Treatment of Myasthenia Gravis: Focus on Pyridostigmine

Author： Maggi Lorenzo   Mantegazza Renato  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.31, Iss.10, 2011-10, pp. : 691-701

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunomodulatory treatment for myasthenia gravis

By  

Inpharma, Vol. 1, Iss. 1283, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Treatment strategies for myasthenia gravis: an update

By Díaz-Manera Jordi   Rojas García Ricard   Illa Isabel  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 13, 2012-09 ,pp. : 1873-1883

Informa Healthcare

Access to resources Recommend Favorite

Ciclosporin is effective in the treatment of patients with severe myasthenia gravis

By  

Inpharma, Vol. 1, Iss. 1489, 2005-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Mood and Anxiety Disorders in Patients with Myasthenia Gravis: Aetiology, Diagnosis and Treatment

By Isin Baral Kulaksizoglu  

CNS Drugs, Vol. 21, Iss. 6, 2007-01 ,pp. : 473-481

Adis International

Access to resources Recommend Favorite

Myasthenia Gravis: Therapy Is Complex

By  

Pharmaceutical Innovation, Vol. 11, Iss. 2, 2002-03 ,pp. : 30-31

Adis International

Access to resources Recommend Favorite